Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed on August 4, 2025, and announced on August 5, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity under the second tranche of a buyback programme announced on July 31, 2025.
| Metric | Value |
|---|---|
| Shares Purchased | 1,418,324 |
| Purchase Date | August 4, 2025 |
| Highest Price Paid | 364.60 pence |
| Lowest Price Paid | 355.90 pence |
| Volume Weighted Average Price | 358.5340 pence |
| Registered Share Capital | 8,984,952,236 ordinary shares |
| Treasury Shares Held | 3,880,205 |
| Voting Shares Outstanding | 8,981,072,031 |
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 1,418,324 ordinary shares. This transaction reduces the number of shares with voting rights to 8,981,072,031.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction. The text notes that a full breakdown of individual trades is available via the London Stock Exchange to comply with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares purchased under the second tranche of the buyback programme announced on July 31, 2025.
- Confirm the updated number of voting shares (8,981,072,031) for compliance with FCA Disclosure Guidance and Transparency Rules.
- Review the individual trade breakdown at the provided London Stock Exchange link for granular pricing data.
- Check the company website (www.haleon.com/investors) for the full announcement and trade details.